BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12165852)

  • 1. Several regions of p53 are involved in repression of RNA polymerase III transcription.
    Stein T; Crighton D; Warnock LJ; Milner J; White RJ
    Oncogene; 2002 Aug; 21(36):5540-7. PubMed ID: 12165852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome.
    Stein T; Crighton D; Boyle JM; Varley JM; White RJ
    Oncogene; 2002 May; 21(19):2961-70. PubMed ID: 12082526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB.
    Crighton D; Woiwode A; Zhang C; Mandavia N; Morton JP; Warnock LJ; Milner J; White RJ; Johnson DL
    EMBO J; 2003 Jun; 22(11):2810-20. PubMed ID: 12773395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J; Lin J; Levine AJ
    Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding.
    Gridasova AA; Henry RW
    Mol Cell Biol; 2005 Apr; 25(8):3247-60. PubMed ID: 15798209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA polymerase III transcription factor IIIB is a target for repression by pocket proteins p107 and p130.
    Sutcliffe JE; Cairns CA; McLees A; Allison SJ; Tosh K; White RJ
    Mol Cell Biol; 1999 Jun; 19(6):4255-61. PubMed ID: 10330166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner.
    Chesnokov I; Chu WM; Botchan MR; Schmid CW
    Mol Cell Biol; 1996 Dec; 16(12):7084-8. PubMed ID: 8943363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hetero-oligomerization does not compromise 'gain of function' of tumor-derived p53 mutants.
    Deb D; Scian M; Roth KE; Li W; Keiger J; Chakraborti AS; Deb SP; Deb S
    Oncogene; 2002 Jan; 21(2):176-89. PubMed ID: 11803461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlapping domains on the p53 protein regulate its transcriptional activation and repression functions.
    Subler MA; Martin DW; Deb S
    Oncogene; 1994 May; 9(5):1351-9. PubMed ID: 8152795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct mechanisms for repression of RNA polymerase III transcription by the retinoblastoma tumor suppressor protein.
    Hirsch HA; Jawdekar GW; Lee KA; Gu L; Henry RW
    Mol Cell Biol; 2004 Jul; 24(13):5989-99. PubMed ID: 15199152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of RNA polymerase I transcription by the tumor suppressor p53.
    Zhai W; Comai L
    Mol Cell Biol; 2000 Aug; 20(16):5930-8. PubMed ID: 10913176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 is a general repressor of RNA polymerase III transcription.
    Cairns CA; White RJ
    EMBO J; 1998 Jun; 17(11):3112-23. PubMed ID: 9606193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maf1, a new player in the regulation of human RNA polymerase III transcription.
    Reina JH; Azzouz TN; Hernandez N
    PLoS One; 2006 Dec; 1(1):e134. PubMed ID: 17205138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
    Liu WL; Midgley C; Stephen C; Saville M; Lane DP
    J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 amino acids 339-346 represent the minimal p53 repression domain.
    Hong TM; Chen JJ; Peck K; Yang PC; Wu CW
    J Biol Chem; 2001 Jan; 276(2):1510-5. PubMed ID: 11007800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor p53 regulates its own transcription.
    Deffie A; Wu H; Reinke V; Lozano G
    Mol Cell Biol; 1993 Jun; 13(6):3415-23. PubMed ID: 7684498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
    Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
    Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA polymerase III transcription and cancer.
    White RJ
    Oncogene; 2004 Apr; 23(18):3208-16. PubMed ID: 15094770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53.
    Pesch J; Brehm U; Staib C; Grummt F
    J Interferon Cytokine Res; 1996 Aug; 16(8):595-600. PubMed ID: 8877730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.